|
| 万孚生物(300482)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-08-25 | 266.80 | 0.55% | 33493.27 | 14648.83 | 30481.37 | 63.32% | 股权激励限售股份 | | 2024-10-08 | 2745.10 | 5.70% | 33226.47 | 14915.63 | 30481.37 | 63.32% | 定向增发机构配售股份 | | 2023-06-07 | 20.61 | 0.05% | 33264.35 | 11187.14 | 33264.35 | 74.83% | 股权激励限售股份 | | 2023-05-31 | 82.49 | 0.19% | 33243.74 | 11207.74 | 33243.74 | 74.79% | 股权激励一般股份 | | 2021-12-08 | 117.34 | 0.26% | 32159.15 | 12336.07 | 32159.15 | 72.28% | 股权激励限售股份 | | 2021-12-01 | 117.99 | 0.27% | 44257.89 | 237.33 | 44495.22 | 100.00% | 股权激励限售流通 | | 2021-08-18 | 9.83 | 0.02% | 44257.85 | 237.33 | 44495.18 | 100.00% | 股权激励限售流通 | | 2021-05-13 | 683.82 | 2.00% | 34060.44 | 198.08 | 34258.52 | 100.00% | 增发A股原股东配售上市 | | 2020-12-15 | 91.77 | 0.27% | 33470.20 | 797.82 | 34268.02 | 100.00% | 股权激励限售流通 | | 2020-09-14 | 6.21 | 0.02% | 33378.42 | 889.60 | 34268.02 | 100.00% | 股权激励限售流通 | | 2019-12-10 | 97.17 | 0.28% | 33372.21 | 897.10 | 34269.32 | 100.00% | 股权激励限售流通 | | 2019-08-09 | 7.56 | 0.02% | 33275.04 | 1011.30 | 34286.34 | 100.00% | 股权激励限售流通 | | 2019-05-13 | 1554.14 | 4.53% | 33267.48 | 1018.86 | 34286.34 | 100.00% | 增发A股法人配售上市 | | 2018-12-14 | 33.35 | 0.10% | 31713.35 | 2579.82 | 34293.17 | 100.00% | 股权激励限售流通 | | 2018-07-02 | 6989.40 | 36.69% | 17600.00 | 1448.46 | 19048.46 | 100.00% | 发行前股份限售流通 | | 2016-06-30 | 6210.60 | 35.29% | 10610.60 | 6989.40 | 17600.00 | 100.00% | 发行前股份限售流通 |
|